Pallas Health vs He & She MD: clinician choice vs coaching app
Quick verdict: For Pallas Health vs He & She MD, choose Pallas Health if you want clinician-selected access to brand-name pens or a per-patient compounded option priced by medication; choose He & She MD if you prioritize a coaching app with 1:1 clinician messaging and bundled tracking at an introductory rate.
Both programs sell GLP-1-based weight-loss plans online, but their core differences are clinician medication choice and pricing structure versus bundled coaching and promo-term pricing. The primary contrast in this Pallas Health vs He & She MD comparison is that Pallas centers on clinician selection between brand-name GLP-1s and compounded preparations, while He & She MD centers on a coaching app and six-month introductory pricing.
See Pallas Health clinician-selected GLP-1 options
How they differ: medication type, pricing structure, and support
The most distinctive supported differences are: (1) whether brand-name FDA-approved GLP-1s are offered alongside compounded medication, (2) how compounded pricing is structured and billed, and (3) the presence of an integrated coaching app and promotional term. We compare these directly below.
1) Medication offerings and clinician role
Pallas Health: A US-licensed clinician reviews your history and can personalize the plan with FDA-approved Wegovy, Ozempic, Zepbound, and Mounjaro, or choose a US-compounded semaglutide or tirzepatide when a brand medication is not the right fit. Pallas does not manufacture or compound medication; compounding is performed by US-licensed pharmacies.
He & She MD: Focuses on compounded GLP-1s in multiple formats: semaglutide injections, oral semaglutide, and tirzepatide injections. Medications require consultation and prescription by a clinician through the platform and not all customers will qualify. Both providers note that compounded medications are not reviewed by the FDA for safety, effectiveness, or quality.
Explore He & She MD coaching and medication formats
2) Pricing and billing cadence
Pallas Health: Compounded semaglutide is $139 for the first month, then $597 every 12 weeks, which the source states is a $199 per month average. Compounded tirzepatide is $179 first month, then $897 every 12 weeks ($299 per month average). Brand-name medications are cash-pay and billed monthly with listed cash-pay figures. Pallas prices compounded plans by medication rather than by milligram, so titration does not raise the plan price. Pallas is cash-pay only and does not bill insurance.
He & She MD: Lists semaglutide injections starting at $139 per month and oral semaglutide or tirzepatide injections at $199 per month as six-month introductory rates. The source says those are promo rates for the first six months; after six months plans renew at a higher six-month price, which the provider presents as a meaningful renewal increase. He & She MD frames the headline prices as six-month intro rates rather than permanent month-to-month pricing.
3) Ongoing support and app features
Pallas Health: Includes provider care, ongoing check-ins, care-team messaging inside the plan price and no membership fee. Pallas offers a self-serve portal for refills, plan changes and messaging plus a free companion app. Care-team hours are weekdays 9 AM to 5 PM ET and no emergency services are offered.
He & She MD: Bundles a coaching app with 1:1 clinician messaging, GLP-1-specific coaching and progress tracking at no extra cost. He & She MD positions that bundled support as the central value proposition for patients who need accountability.
Check Pallas Health plan details and shipping
Side-by-side snapshot
| Criteria | Pallas Health | He & She MD |
|---|---|---|
| Medication types | Brand-name FDA-approved GLP-1s plus US-compounded semaglutide and tirzepatide | Compounded semaglutide (injectable and oral) and tirzepatide injections |
| Intro price example | Compounded semaglutide $139 first month then $597 per 12 weeks ($199/mo avg) | Semaglutide injections from $139/mo as a six-month intro rate (renews higher) |
| Support included | Clinician review, ongoing check-ins, messaging included in plan | Coaching app with 1:1 clinician messaging and tracking included |
| Billing cadence | Compounded plans renew every 12 weeks; brand meds billed monthly | Structured as six-month terms with introductory rates for six months |
| Shipping | Free expedited and discreet shipping from US compounding pharmacies | Free expedited shipping; medications shipped to your door |
Regulatory and eligibility notes
Both sources state that compounded medications are not reviewed by FDA for safety, effectiveness or quality. Pallas states eligibility is determined by a US-licensed clinician and is cash-pay only. He & She MD notes medications require consultation and prescription and that not all customers will qualify.
Start Pallas Health intake and check eligibility
Conclusion and who should choose which
In this Pallas Health vs He & She MD comparison, choose based on whether clinician medication choice or built-in coaching is more important. Pallas Health is centered on clinician selection between brand-name pens and patient-specific compounded preparations, with compounded semaglutide from $139 first month then billed every 12 weeks and provider care included in the plan price. He & She MD bundles a coaching app with 1:1 clinician messaging and progress tracking and promotes lower six-month introductory rates that renew higher after the promo term.
Choose Pallas Health if you want a clinician to pick between a brand-name GLP-1 pen and a per-patient compounded preparation, value pricing by medication rather than by milligram, and prefer provider care included with no membership fee.
Choose He & She MD if you want coaching and 1:1 clinician messaging and are comfortable with six-month introductory pricing that renews at a higher six-month rate.
Primary keyword: Pallas Health vs He & She MD